Literature DB >> 14724584

The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.

Pierfrancesco Vargiu1, Ricardo De Abajo, Juan Antonio Garcia-Ranea, Alfonso Valencia, Pilar Santisteban, Piero Crespo, Juan Bernal.   

Abstract

The Ras homolog enriched in striatum, Rhes, is the product of a thyroid hormone-regulated gene during brain development. Rhes and the dexamethasone-induced Dexras1 define a novel distinct subfamily of proteins within the Ras family, characterized by an extended variable domain in the carboxyl terminal region. We have carried this study because there is a complete lack of knowledge on Rhes signaling. We show that in PC12 cells, Rhes is targeted to the plasma membrane by farnesylation. We demonstrate that about 30% of the native Rhes protein is bound to GTP and this proportion is unaltered by typical Ras family nucleotide exchange factors. However, Rhes is not transforming in murine fibroblasts. We have also examined the role of Rhes in cell signaling. Rhes does not stimulate the ERK pathway. By contrast, it binds to and activates PI3K. On the other hand, we demonstrate that Rhes impairs the activation of the cAMP/PKA pathway by thyroid-stimulating hormone, and by an activated beta2 adrenergic receptor by a mechanism that suggests uncoupling of the receptor to its cognate heterotrimeric complex. Overall, our results provide the initial insights into the role in signal transduction of this novel Ras family member.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724584     DOI: 10.1038/sj.onc.1207161

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Striatum specific protein, Rhes regulates AKT pathway.

Authors:  Sookhee Bang; Catherine Steenstra; Sangwon F Kim
Journal:  Neurosci Lett       Date:  2012-06-06       Impact factor: 3.046

2.  PKA modulates iron trafficking in the striatum via small GTPase, Rhes.

Authors:  Bo-Ran Choi; Sookhee Bang; Yong Chen; Jaime H Cheah; Sangwon F Kim
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

3.  Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.

Authors:  P Agretti; G De Marco; A Pinchera; P Vitti; J Bernal; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

4.  Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.

Authors:  Srinivasa Subramaniam; Katherine M Sixt; Roxanne Barrow; Solomon H Snyder
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

5.  Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.

Authors:  Juan I Sbodio; Bindu D Paul; Carolyn E Machamer; Solomon H Snyder
Journal:  Cell Rep       Date:  2013-09-05       Impact factor: 9.423

6.  Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.

Authors:  Laura M Harrison; Youe He
Journal:  J Neurosci Res       Date:  2011-03-03       Impact factor: 4.164

7.  Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.

Authors:  Robert G Mealer; Alexandra J Murray; Neelam Shahani; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

8.  Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Authors:  L M Harrison; S H Muller; D Spano
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

Review 9.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

10.  Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.

Authors:  Robert G Mealer; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.